| Unique ID issued by UMIN | UMIN000062812 |
|---|---|
| Receipt number | R000071868 |
| Scientific Title | Effect of shoe lift height on oxygen consumption during walking with a knee-ankle-foot orthosis |
| Date of disclosure of the study information | 2026/09/03 |
| Last modified on | 2026/09/03 19:29:04 |
Effects of shoe height on the opposite side on energy expenditure during walking with a leg brace
Shoe height and energy expenditure during walking with a leg brace
Effect of shoe lift height on oxygen consumption during walking with a knee-ankle-foot orthosis
Shoe lift height and oxygen consumption during KAFO walking
| Japan |
Healthy adults
| Adult |
Others
NO
The purpose of this study is to investigate the effects of different contralateral shoe lift heights on oxygen consumption during walking with a knee-ankle-foot orthosis (KAFO) in healthy adults.
Efficacy
Exploratory
Explanatory
Not applicable
Oxygen consumption (VO2). VO2 will be measured using a respiratory gas analyzer during 6-minute treadmill walking under each condition, and the mean value from 3 to 6 minutes after the start of walking will be evaluated.
Carbon dioxide output (VCO2), heart rate (HR), respiratory rate (RR), minute ventilation (VE), tidal volume (TV), modified Borg Scale, center of mass, walking speed, step length, stride length, lateral circumduction of the lower limb during the swing phase of walking, pelvic lateral tilt in the frontal plane, and excessive vertical elevation of the trunk and pelvis will be evaluated. Respiratory gas-related variables will be measured during 6-minute treadmill walking under each condition, and the mean values from 3 to 6 minutes after the start of walking will be evaluated.
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
No treatment
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
4
Treatment
| Device,equipment |
Walking without a knee-ankle-foot orthosis (KAFO) or shoe lift. For respiratory gas analysis, participants walk on a treadmill for 6 minutes at the predetermined comfortable walking speed. For three-dimensional motion analysis, participants walk along an approximately 6-m walkway at a comfortable walking speed.
Walking with a knee-ankle-foot orthosis (KAFO) and without a shoe lift on the contralateral side (0-cm condition). For respiratory gas analysis, participants walk on a treadmill for 6 minutes at the predetermined comfortable walking speed. For three-dimensional motion analysis, participants walk along an approximately 6-m walkway at a comfortable walking speed.
Walking with a knee-ankle-foot orthosis (KAFO) and a 1.0-cm shoe lift on the contralateral side. For respiratory gas analysis, participants walk on a treadmill for 6 minutes at the predetermined comfortable walking speed. For three-dimensional motion analysis, participants walk along an approximately 6-m walkway at a comfortable walking speed.
Walking with a knee-ankle-foot orthosis (KAFO) and a 2.0-cm shoe lift on the contralateral side. For respiratory gas analysis, participants walk on a treadmill for 6 minutes at the predetermined comfortable walking speed. For three-dimensional motion analysis, participants walk along an approximately 6-m walkway at a comfortable walking speed.
| 18 | years-old | <= |
| Not applicable |
Male and Female
1.Healthy adults aged 18 years or older
2.Individuals who have no difficulty walking in daily life and are able to walk independently without assistive devices
3.Individuals without apparent orthopedic or neurological disorders of the lower limbs or trunk that may affect walking
4.Individuals who have received and understood a sufficient explanation of the purpose and procedures of the study and provided written informed consent
1.Individuals with a history of lower-limb fracture or surgery that may affect joint range of motion, muscle strength, or gait pattern
2.Individuals with brain or spinal cord disorders, peripheral neuropathy, balance disorders, or other conditions that may affect the safety or stability of walking
3.Individuals with hypertension, ischemic heart disease, asthma, or other conditions that may pose a health risk during exercise testing or respiratory gas analysis
4.Individuals with apparent lower-limb deformity or a leg length discrepancy of 1.0 cm or greater
5.Individuals with wounds, skin disorders, inflammation, or pain at the sites of contact with the knee-ankle-foot orthosis, for whom orthosis use may worsen symptoms
30
| 1st name | Satoru |
| Middle name | |
| Last name | Ebihara |
Tohoku University Graduate School of Medicine
Department of Clinical Disability Sciences
980-8574
1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi
022-717-7353
satoru.ebihara.c4@tohoku.ac.jp
| 1st name | Hiroshi |
| Middle name | |
| Last name | Sayuuda |
Tohoku University Graduate School of Medicine
Department of Clinical Disability Sciences
980-8574
4-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi
022-728-6053
sayuuda.hiroshi.q7@dc.tohoku.ac.jp
Tohoku University
None
Self funding
Ethics Committee Tohoku University Graduate School of Medicine
2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi
022-728-4105
ec-med@grp.tohoku.ac.jp
NO
東北保健医療専門学校(宮城県)
| 2026 | Year | 09 | Month | 03 | Day |
Unpublished
Preinitiation
| 2026 | Year | 08 | Month | 21 | Day |
| 2026 | Year | 08 | Month | 27 | Day |
| 2026 | Year | 09 | Month | 07 | Day |
| 2027 | Year | 03 | Month | 10 | Day |
| 2027 | Year | 03 | Month | 15 | Day |
| 2027 | Year | 03 | Month | 20 | Day |
| 2027 | Year | 03 | Month | 31 | Day |
| 2026 | Year | 09 | Month | 03 | Day |
| 2026 | Year | 09 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071868